𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)

✍ Scribed by Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, Sung Cheol (author);Park, Duk Woo (author);Lee, Cheol Whan (author);Hong, Myeong Ki (author);Kim, Hyun Sook (author);Ko, Jae Ki (author);Park, Jae Hyeong (author);Lee, Jae Hwan (author);Choi, Si Wan (author);Seong, In Whan (author);Cho, Yoon Haeng (author);Lee, Nae Hee (author);Kim, June Hong (author);Chun, Kook Jin (author);Park, Seung Jung (author)

Book ID
119267243
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
483 KB
Volume
51
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Drug-Eluting Stenting Followed by Cilost
Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)
✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 483 KB
A Randomized, Double-Blind, Multicenter
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial
✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 653 KB